Literature DB >> 9885980

Functional and molecular analyses of 10q deletions in human gliomas.

P A Steck1, H Lin, L A Langford, S A Jasser, D Koul, W K Yung, M A Pershouse.   

Abstract

Extensive genomic deletions involving chromosome 10 are the most common genetic alteration in glioblastoma multiforme (GBM). To localize and examine the potential roles of two chromosome arm 10q tumor suppressor regions, we used two independent strategies: mapping of allelic deletions, and functional analysis of phenotypic suppression after transfer of chromosome 10 fragments. By allelic deletion analysis, the region of 10q surrounding the MMAC/PTEN locus was shown to be frequently lost in GBMs but maintained in most low-grade astrocytic tumors. An additional region at 10q25 containing the DMBT1 locus was lost in all grades of gliomas examined. The potential biological significance of these two regions was further assessed by examining microcell hybrids that contained various fragments of 10q. Somatic cell hybrid clones that retained the MMAC/PTEN locus have a less transformed phenotype with clones exhibiting an inability to grow in soft agarose. However, presence or absence of DMBT1 did not correlate with any in vitro phenotype assessed in our model system. These results support a model of molecular progression in gliomas in which the frequent deletion of 10q25-26 is an early event and is followed by the deletion of the MMAC/PTEN during the progression to high-grade GBMs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9885980     DOI: 10.1002/(sici)1098-2264(199902)24:2<135::aid-gcc6>3.0.co;2-a

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

1.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

2.  Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review).

Authors:  Xiang Zhang; Wei Zhang; Wei-Dong Cao; Gang Cheng; Yong-Qiang Zhang
Journal:  Exp Ther Med       Date:  2011-10-18       Impact factor: 2.447

3.  PAX6 suppresses growth of human glioblastoma cells.

Authors:  Yi-Hong Zhou; Xiaosong Wu; Fang Tan; Yue-Xi Shi; Tricia Glass; T J Liu; Kyle Wathen; Kenneth R Hess; Joy Gumin; Frederick Lang; W K Alfred Yung
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

4.  Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population.

Authors:  M Moshahid Alam Rizvi; M Shabbir Alam; Syed Jafar Mehdi; Asgar Ali; Swaraj Batra
Journal:  Pathol Oncol Res       Date:  2011-09-08       Impact factor: 3.201

5.  Inhibition of transfected PTEN on human colon cancer.

Authors:  Shou-Shui Xu; Wen-Lu Shen; Song-Ying Ouyang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

6.  Human leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14.

Authors:  Franca R Guerini; Cristina Agliardi; Milena Zanzottera; Serena Delbue; Elisabetta Pagani; Carmine Tinelli; Renzo Boldorini; Pier Giorgio Car; Claudia Veggiani; Pasquale Ferrante
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

7.  Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.

Authors:  Kinya Terada; Takashi Tamiya; Shigeru Daido; Hirokazu Kambara; Hiroaki Tanaka; Yasuhiro Ono; Kengo Matsumoto; Sachio Ito; Mamoru Ouchida; Takashi Ohmoto; Kenji Shimizu
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

8.  An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma.

Authors:  Hassan M Minhas; Matthew F Pescosolido; Matthew Schwede; Justyna Piasecka; John Gaitanis; Umadevi Tantravahi; Eric M Morrow
Journal:  Am J Med Genet A       Date:  2013-03-12       Impact factor: 2.802

9.  Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.

Authors:  Daniel J Brat; Wendy F Seiferheld; Arie Perry; Elizabeth H Hammond; Kevin J Murray; Alan R Schulsinger; Minesh P Mehta; Walter J Curran
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

10.  Long-Term Survival of a Patient with Giant Cell Glioblastoma: Case Report and Review of the Literature.

Authors:  E Naydenov; V Bussarsky; S Nachev; S Hadjidekova; D Toncheva
Journal:  Case Rep Oncol       Date:  2009-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.